Kaleido

Utrecht, Netherlands · Founded 2013 · Privately Held (backing)

Developer of medical devices designed to be used for the treatment of diabetes. Kaleido is based in Utrecht, Netherlands and was founded in 2013. It has raised $194 million.

Last price · $/share
—
Implied valuation
—
Total raised
$193.6M
Last round
—
Valuation — not yet established

No valuation for Kaleido is on record yet — no priced round, mark, or trade has surfaced in our sources. Total raised ($193.6M) and the funding record below are the closest available signals.

Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Kaleido with a free account
  • ·Watch Kaleido: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

Kaleido funding history

No rounds on record

No funding rounds for Kaleido are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.

Pro members can request priority coverage with a 48-hour turnaround.

How Kaleido's valuation is determined

Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.

For Kaleido, too few pricing signals exist to publish a composite mark; the figures above reflect the most recent observed valuation event. Full methodology →

Frequently asked about Kaleido

How much has Kaleido raised?
Kaleido has raised $193.6M in total funding across its recorded rounds.